text size A A A

Osteoinductive

Stryker has invested over 20 years of research in developing OP-1 (Osteogenic Protein-1, BMP-7), a naturally occurring osteoinductive protein that has demonstrated the ability to stimulate, repair, and regenerate bone*. Stryker offers OP-1 products for trauma and spine indications and is developing products based on BMP-7 for a number of clinical specialties including degenerative disc disease, osteoarthritis, and sports medicine. The long-term goal is to establish a family of skeletal repair products based on BMP-7 that will address the needs of a broad range of surgical specialties.




OP-1/BMP-7
Product List
 
 
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademark(s) or service mark(s): OP-1. All other trademarks are trademarks of their respective owners or holders.

*G. E. Friedlaender, MD, C. R. Perry, MD, J. D. Cole, MD, S. D. Cook, PhD, G. Cierny, MD, G. F. Muschler, MD, G. A. Zych, DO, J. H. Calhoun, MD, A. J. LaForte, PhD and S. Yin, PhD. Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft. The Journal of Bone and Joint Surgery (American) 83:S151-S158 (2001).